Clinical experience of prophylactic enoxaparin dosage adjustment guided by AntiXa factor levels in critical care patients with COVID-19-induced pneumonia: observational study()

Detalles Bibliográficos
Autores principales: Bermúdez-Ruiz, María del Carmen, Vilar Sánchez, Irene, Aparicio Pérez, Clara, Carmona Flores, Rosario, Rodríguez-Gómez, Jorge, de la Fuente-Martos, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier España, S.L.U. 2023
Materias:
Scientific Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201310/
https://www.ncbi.nlm.nih.gov/pubmed/37308357
http://dx.doi.org/10.1016/j.medine.2023.05.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201310/
https://www.ncbi.nlm.nih.gov/pubmed/37308357
http://dx.doi.org/10.1016/j.medine.2023.05.009

Ejemplares similares